Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Primary central nervous system lymphoma in Japan: Changes in clinical features, treatment, and prognosis during 1985-2004.

Primary central nervous system lymphoma in Japan: Changes in clinical features, treatment, and prognosis during 1985-2004. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Primary central nervous system lymphoma in Japan: Changes in clinical features, treatment, and prognosis during 1985-2004. Abstract Text:

    We have conducted nationwide surveys of primary central nervous system lymphoma (PCNSL) treated since 1985. In the present study, we newly collected data between 2000 and 2004 and investigated changes in clinical features and outcome over time. A total of 739 patients with histologically proven PCNSL under going radiotherapy were analyzed. Seventeen institutions were surveyed, and data on 131 patients were collected. These data were compared with updated data that were previously obtained for 466 patients treated during 1985-1994 and 142 patients treated during 1995-1999. Recent trends toward decrease in male/female ratio, increase in aged patients, and increase in patients with multiple lesions were seen. Regarding treatment, decrease in attempts at surgical tumor removal and increases in use of systemic chemotherapy and methotrexate (MTX)-containing regimens were observed. The median survival time was 18, 29, and 24 months for patients seen during 1985-1994, 1995-1999, and 2000-2004, respectively, and the respective 5-year survival rates were 15%, 30%, and 30%. In groups seen during 1995-1999 and during 2000-2004, patients who received systemic or MTX-containing chemotherapy had better prognosis than those who did not. Multivariate analysis of all patients seen during 1985-2004 suggested the usefulness of MTX-containing chemotherapy as well as the importance of age, lactate dehydrogenase level, and tumor multiplicity as prognostic factors. Thus, this study revealed several notable changes in clinical features of PCNSL patients. The prognosis improved during the last 10 years. Advantage of radiation plus chemotherapy, especially MTX-containing chemotherapy, over radiation alone was suggested.

    Primary central nervous system lymphoma in Japan: Changes in clinical features, treatment, and prognosis during 1985-2004. Publishing Authors By Initials

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Primary central nervous system lymphoma in Japan: Changes in clinical features, treatment, and prognosis during 1985-2004. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Neuro-oncology

    VOLUME: 10

    Page Numbers: 560-8

    Journal Abbreviation: Neuro-oncology

    ISSN: 1522-8517

    DAY: 17

    MONTH: 06

    YEAR: 2008

    Primary central nervous system lymphoma in Japan: Changes in clinical features, treatment, and prognosis during 1985-2004. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 100887420

    Primary central nervous system lymphoma in Japan: Changes in clinical features, treatment, and prognosis during 1985-2004. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Primary central nervous system lymphoma in Japan: Changes in clinical features, treatment, and prognosis during 1985-2004. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Primary central nervous system lymphoma in Japan: Changes in clinical features, treatment, and prognosis during 1985-2004.

    AFFILIATION: Department of Radiology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Nagoya 467-8601, Japan. yshiba@med.nagoya-cu.ac.jp.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Neuro Oncol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Primary central nervous system lymphoma in Japan: Changes in clinical features, treatment, and prognosis during 1985-2004 Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News